Innate Pharma Cash Flow Statement (2017-2025) | IPHA

Cash Flow Statement Dec2017 Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Operating Activities
Net Income -0.08B-0.05B-0.00B-0.01B-0.05B
Gains from Sales and Divestitures 0.00B0.00B0.00B0.00B0.00B
Gains from Investment Securities -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.10B
Change in Working Capital 0.00B
Change in Account Payables 0.04B0.04B-0.04B0.03B-0.04B0.02B-0.04B0.02B-0.03B0.02B-0.03B
Cash from Operations -0.06B-0.07B-0.02B-0.04B-0.01B
Investing Activities
Sales of Property, Plant and Equipment -0.00B0.00B0.00B
Change in Intangibles -0.07B-0.01B-0.00B-0.00B-0.00B
Cash from Investing Activities -0.07B-0.02B-0.00B
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments -0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
Misc.
Cash from Financing Activities -0.00B-0.00B-0.00B-0.01B
Exchange Rate Effect -0.00B-0.00B-0.00B
Change in Cash -0.08B-0.04B-0.02B-0.01B-0.00B
Beginning Cash Balance 0.12B0.17B0.22B131.54B0.24B0.13B0.16B0.11B0.11B0.08B0.09B0.08B0.08B0.06B
Free Cash Flow -0.06B-0.07B-0.02B-0.04B-0.01B
Net Cash Flow -0.07B-0.08B-0.07B-0.02B-0.04B-0.01B